title: Successful Treatment of Chromobacterium violaceum Sepsis in a South Indian Adult.
abstract: Infection due to Chromobacterium violaceum is rare. Diagnosis may be delayed since Chromobacterium sepsis may mimic melioidosis, especially in melioidosis-endemic areas. Management of Chromobacterium infection is challenging given the propensity of this pathogen to cause visceral abscesses, drug resistance, and relapse. Mortality rates are high despite treatment. We report a case of C. violaceum septicemia in an immunocompetent adult from south India, who was successfully treated with combination antibiotic therapy. Physicians in tropical and subtropical regions must be aware of C. violaceum infection as it can mimic melioidosis.
authors: Department of Medicine and Department of Microbiology, Kasturba Medical College, Mangalore (affiliated to Manipal University), Karnataka, India; Department of Pediatrics, Wake Forest School of Medicine, Winston-Salem, North Carolina.
authors: Deepak R
authors: DR
authors: Madi
authors: Department of Medicine and Department of Microbiology, Kasturba Medical College, Mangalore (affiliated to Manipal University), Karnataka, India; Department of Pediatrics, Wake Forest School of Medicine, Winston-Salem, North Carolina.
authors: K
authors: K
authors: Vidyalakshmi
authors: Department of Medicine and Department of Microbiology, Kasturba Medical College, Mangalore (affiliated to Manipal University), Karnataka, India; Department of Pediatrics, Wake Forest School of Medicine, Winston-Salem, North Carolina.
authors: John
authors: J
authors: Ramapuram
authors: Department of Medicine and Department of Microbiology, Kasturba Medical College, Mangalore (affiliated to Manipal University), Karnataka, India; Department of Pediatrics, Wake Forest School of Medicine, Winston-Salem, North Carolina ashetty@wakehealth.edu.
authors: Avinash K
authors: AK
authors: Shetty
mesh_terms: D000038:Abscess; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002861:Chromobacterium / Q000302:isolation & purification*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage*; D007194:India; D008554:Melioidosis / Q000382:microbiology; D008875:Middle Aged; D018805:Sepsis / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D015378:Imipenem